Anti-eIF4A3 antibody [EPR14301(B)]
- RabMAb
- Recombinant
- What is this?
5
(5 Reviews)
|
(27 Publications)
Rabbit Recombinant Monoclonal eIF4A3 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 27 publications.
View Alternative Names
DDX48, KIAA0111, EIF4A3, Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, ATP-dependent RNA helicase DDX48, ATP-dependent RNA helicase eIF4A-3, DEAD box protein 48, Eukaryotic initiation factor 4A-like NUK-34, Eukaryotic translation initiation factor 4A isoform 3, Nuclear matrix protein 265, NMP 265, hNMP 265
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Immunohistochemical analysis of formalin fixed paraffin embedded Human spleen tissue labelling eIF4A3 with ab180573 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Sections were counterstained with Hematoxylin.
Positive staining on human spleen.
The section was incubated with ab180573 at 4°C overnight.
Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH9.0)
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Immunohistochemical analysis of paraffin-embedded Human prostate tissue labeling eIF4A3 with ab180573 at 1/100 dilution. Prediluted (ready to use) HRP Polymer for Rabbit IgG was used as a secondary antibody. Counter stain : Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervix adenocarcinoma epithelial cell) cells labelling eIF4A3 with ab180573 at 1/100 (9.39 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green).
Nuclear DNA was labelled with DAPI (shown in blue). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5ug/ml) dilution (Red).
Confocal image showing nuclear staining in HeLa cells.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized MCF7 (human breast adenocarcinoma epithelial cell) cells labelling eIF4A3 with ab180573 at 1/90 dilution (1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
Goat anti rabbit IgG (Alexa Fluor® 488, ab150097) at 1/5000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Immunofluorescent analysis of 4% paraformaldehyde MCF7 cells labeling eIF4A3 with ab180573 at 1/500 dilution (green), or with Dapi counter stain (blue). Goat anti rabbit IgG (Dylight 488) was used as a secondary antibody, at a dilution of 1/200.
- IP
Lab
Immunoprecipitation - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
eIF4A3 was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab180573 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab180573 at 1/500 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate, 10 µg
Lane 2 : HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab180573 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-eIF4A3 antibody [EPR14301(B)] (ab180573) at 1/500 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 10 µg
Lane 2:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab180573 in HeLa whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 47 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Blocking and diluting buffer and concentration : 5% NFDM /TBST
ab181602 was used as a GAPDH loading control.
ab180573 has a faint band above the target band, we recommend using ab180519 to get desire result in western blot.
All lanes:
Western blot - Anti-eIF4A3 antibody [EPR14301(B)] (ab180573) at 1/1000 dilution
Lane 1:
SK-OV-3 (Human ovarian cancer epithelial cell) whole cell lysate at 20 µg
Lane 2:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
A549 (Human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 7:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa
Observed band size: 46 kDa
false
- WB
Lab
Western blot - Anti-eIF4A3 antibody [EPR14301(B)] (AB180573)
Blocking and dilution buffer : 5% NFDM/TBST.
Anti-DDDDK tag (Binds to FLAG® tag sequence) antibody (ab205606) used as loading control at 1/1000 dilution. The secondary antibody used is ab97051, a HRP goat anti-rabbit IgG (H+L), at a dilution of 1/20000.
All lanes:
Western blot - Anti-eIF4A3 antibody [EPR14301(B)] (ab180573) at 1/1000 dilution
Lane 1:
eIF4A1 Human Recombinant Protein at 10 ng
Lane 2:
eIF4A2 Human Recombinant Protein at 10 ng
Lane 3:
eIF4A3 Human Recombinant Protein at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa
Observed band size: 46 kDa
false
Exposure time: 5s
Related conjugates and formulations (4)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-eIF4A3 antibody [EPR14301(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-eIF4A3 antibody [EPR14301(B)]
-
Anti-eIF4A3 antibody [EPR14301(B)] - BSA and Azide free
-
578 PE
PE Anti-eIF4A3 antibody [EPR14301(B)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4A3 engages in nonsense-mediated mRNA decay and plays a role in mRNA splicing. It is an important component of the exon junction complex (EJC) which includes other proteins like MAGOH and Y14. This complex ensures proper mRNA surveillance by marking transcripts that need to be subject to degradation if errors are found.
Pathways
EIF4A3 interacts with cellular processes such as mRNA surveillance and splicing. It integrates within the nonsense-mediated decay (NMD) pathway and the spliceosome-associated pathways. eIF4A3's activity closely relates to proteins like UPF1 and RNPS1 which coordinate the removal of defective mRNA and support mRNA splicing.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Research (Washington, D.C.) 8:0703 PubMed40416363
2025
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics 20:2482382 PubMed40145872
2025
Applications
Unspecified application
Species
Unspecified reactive species
Virology journal 22:73 PubMed40082995
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 41:e12943 PubMed39810713
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:29278 PubMed39587118
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 52:12039-12054 PubMed39225047
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:19972 PubMed39198460
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 43:114666 PubMed39182224
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e18465 PubMed39022816
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 46:101996 PubMed38795560
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com